Onset of mucosal, dermal, and general symptoms in relation to biomarkers and exposures in the dwelling: a cohort study from 1992 to 2002.

UNLABELLED We examined the associations between biomarkers of allergy and inflammation, indoor environment in dwellings, and incidence and remission of symptoms included in the sick building syndrome (SBS) and changes in the home environment of 452 adults who were followed from 1992 to 2002 within the Uppsala part of the European Community Respiratory Health Survey (ECRHS). The 10-year incidence (onset) of general, mucosal, and dermal symptoms was 8.5%, 12.7%, and 6.8%, respectively. Dampness or indoor molds at baseline was a predictor of incidence of general (relative risk [RR] = 1.98), mucosal (RR = 2.28), and dermal symptoms (RR = 1.91). Women had higher incidence of general (RR = 1.74) and mucosal symptoms (RR = 1.71). Indoor painting increased the incidence of general symptoms (RR = 1.62). Bronchial responsiveness (BR), eosinophil counts in blood, total IgE and eosinophilic cationic protein (ECP) in serum at baseline were predictors of incidence of SBS. At follow-up, BR, total IgE, and C-reactive protein (CRP ) were associated with increased incidence of SBS. Moreover, subjects with doctor-diagnosed asthma at baseline had a higher incidence of general (RR = 1.65) and mucosal symptoms (RR = 1.97). In conclusion, female gender, dampness or indoor molds, indoor painting, and biomarkers of allergy and inflammation were associated with a higher incidence of SBS symptoms, in particular mucosal symptoms. PRACTICAL IMPLICATIONS The focus in Sweden on indoor environment issues over the last few decades has resulted in improvements in dwellings, and reduced tobacco smoking, which could be beneficial for public health. Reducing dampness and molds in the dwelling place is another important way of reducing occurrence of SBS symptoms in the general adult population. The association between the incidence of SBS symptoms and clinical biomarkers of allergy and inflammation suggests a common etiology between inflammatory diseases, including asthma, rhinitis, and SBS. Lastly, good agreement between self-reported and clinically diagnosed atopy indicates that questionnaire data on atopy can be used in epidemiological studies.

[1]  D. Norbäck,et al.  Sick building syndrome in relation to domestic exposure in Sweden - A cohort study from 1991 to 2001 , 2010, Scandinavian journal of public health.

[2]  A. Buist,et al.  Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. , 2009, Respiratory medicine.

[3]  D. Norbäck,et al.  Indoor environment in dwellings, asthma, allergies, and sick building syndrome in the Swedish population: a longitudinal cohort study from 1989 to 1997 , 2009, International archives of occupational and environmental health.

[4]  M J Mendell,et al.  Quantitative relationship of sick building syndrome symptoms with ventilation rates. , 2009, Indoor air.

[5]  Dan Norbäck,et al.  An update on sick building syndrome , 2009, Current opinion in allergy and clinical immunology.

[6]  A. Buist,et al.  Hypertension, Systemic Inflammation and Body Weight in Relation to Lung Function Impairment—An Epidemiological Study , 2009, COPD.

[7]  E. Heseltine,et al.  WHO guidelines for indoor air quality : dampness and mould , 2009 .

[8]  L. Shek,et al.  Eosinophil cationic protein : Is it useful in asthma ? , 2007 .

[9]  D. Norbäck,et al.  Pet keeping and dampness in the dwelling: associations with airway infections, symptoms, and physiological signs from the ocular and nasal mucosa. , 2007, Indoor air.

[10]  F. Sung,et al.  Oxidative Stress Associated with Indoor Air Pollution and Sick Building Syndrome-Related Symptoms among Office Workers in Taiwan , 2007, Inhalation toxicology.

[11]  P. Venge,et al.  Monitoring the allergic inflammation , 2004, Allergy.

[12]  D. Jarvis,et al.  The European Community Respiratory Health Survey II , 1994, European Respiratory Journal.

[13]  D. Norbäck,et al.  Biomarkers and chemosensory irritations , 2002, International archives of occupational and environmental health.

[14]  F Neukirch,et al.  The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. , 2001, The European respiratory journal.

[15]  G. Pershagen,et al.  Dampness in buildings and health. Nordic interdisciplinary review of the scientific evidence on associations between exposure to "dampness" in buildings and health effects (NORDDAMP). , 2001, Indoor air.

[16]  Dan Norbäck,et al.  Nasal Lavage Biomarkers: Effects of Water Damage and Microbial Growth in an Office Building , 2001, Archives of environmental health.

[17]  P. Fanger,et al.  The effects of outdoor air supply rate in an office on perceived air quality, sick building syndrome (SBS) symptoms and productivity. , 2000, Indoor air.

[18]  D. Koller.  Sampling methods: urine/blood analysis. , 2000, American journal of respiratory and critical care medicine.

[19]  W. Fisk,et al.  Association of ventilation rates and CO2 concentrations with health and other responses in commercial and institutional buildings. , 1999, Indoor air.

[20]  D. Norbäck,et al.  Inflammation markers in nasal lavage, and nasal symptoms in relation to relocation to a newly painted building: a longitudinal study , 1999, International archives of occupational and environmental health.

[21]  Venge,et al.  Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  C. Janson,et al.  Current asthma and biochemical signs of inflammation in relation to building dampness in dwellings. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[23]  C. Janson,et al.  Symptoms related to the sick building syndrome in a general population sample: associations with atopy, bronchial hyper-responsiveness and anxiety. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[24]  S. Chinn.  Choosing a transformation , 1996 .

[25]  C. Janson,et al.  Eosinophil peroxidase: a new serum marker of atopy and bronchial hyper-responsiveness. , 1996, Respiratory medicine.

[26]  M. Hodgson.  The sick-building syndrome. , 1995, Occupational medicine.

[27]  A. Apter,et al.  Epidemiology of the sick building syndrome. , 1994, The Journal of allergy and clinical immunology.

[28]  Mark J. Mendell,et al.  Non‐Specific Symptoms In Office Workers: A Review And Summary Of The Epidemiologic Literature , 1993 .

[29]  T. Haahtela,et al.  Serum myeloperoxidase and sick building syndrome , 1993, The Lancet.

[30]  M. Sears,et al.  Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. , 1991, The New England journal of medicine.

[31]  D. Norbäck,et al.  Environmental, occupational, and personal factors related to the prevalence of sick building syndrome in the general population. , 1991, British journal of industrial medicine.

[32]  F. Martinez,et al.  Association of asthma with serum IgE levels and skin-test reactivity to allergens. , 1989, The New England journal of medicine.